LUMIRADX LTD (LMDX) Stock Price & Overview
NASDAQ:LMDX • KYG5709L1095
The current stock price of LMDX is 0.016 USD. Today LMDX is down by -53.49%. In the past month the price decreased by -84.1%. In the past year, price decreased by -98.21%.
LMDX Key Statistics
- Market Cap
- 2.629M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.09
- Dividend Yield
- N/A
LMDX Stock Performance
LMDX Stock Chart
LMDX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to LMDX. When comparing the yearly performance of all stocks, LMDX is a bad performer in the overall market: 99.78% of all stocks are doing better.
LMDX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to LMDX. Both the profitability and financial health of LMDX have multiple concerns.
LMDX Earnings
LMDX Forecast & Estimates
8 analysts have analysed LMDX and the average price target is 1.22 USD. This implies a price increase of 7550% is expected in the next year compared to the current price of 0.016.
For the next year, analysts expect an EPS growth of 70.33% and a revenue growth -64.72% for LMDX
LMDX Groups
Sector & Classification
LMDX Financial Highlights
Over the last trailing twelve months LMDX reported a non-GAAP Earnings per Share(EPS) of -1.09. The EPS increased by 1.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -99.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
LMDX Ownership
LMDX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.25 | 192.101B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.54 | 172.54B | ||
| SYK | STRYKER CORP | 23.71 | 137.252B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.01 | 103.813B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.85 | 49.778B | ||
| IDXX | IDEXX LABORATORIES INC | 40.4 | 47.68B | ||
| BDX | BECTON DICKINSON AND CO | 12.02 | 46.663B | ||
| RMD | RESMED INC | 20.12 | 35.999B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.07 | 33.147B | ||
| DXCM | DEXCOM INC | 26.66 | 26.09B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.82 | 17.941B | ||
| HOLX | HOLOGIC INC | 15.39 | 16.864B | ||
| PODD | INSULET CORP | 36.85 | 16.772B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About LMDX
Company Profile
LumiraDX Ltd. is a next-generation point of care diagnostics company, which engages in the provision of an innovative diagnostic platform that supports a menu of tests with lab-comparable performance at the point of care. The firm is focused on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need. The firm has developed and launched the LumiraDx Platform, which is an integrated system comprised of a small, versatile Instrument, low-cost microfluidic Test Strips, and seamless, secure digital connectivity. The firm offers a menu of lab comparable tests on a single portable platform, with more than 30 assays on the market and in various stages of development, covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders. The company also supports laboratory testing in an accessible high-throughput format to leverage molecular laboratory operations. Its diagnostic testing solutions are being deployed globally by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools and others.
Company Info
IPO: 2021-03-09
LUMIRADX LTD
PO Box 1350, Windward 3, Regatta Office
George Town KY
CEO: Larry J. Neiterman
Employees: 1210
Phone: 13546400540
LUMIRADX LTD / LMDX FAQ
Can you describe the business of LUMIRADX LTD?
LumiraDX Ltd. is a next-generation point of care diagnostics company, which engages in the provision of an innovative diagnostic platform that supports a menu of tests with lab-comparable performance at the point of care. The firm is focused on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need. The firm has developed and launched the LumiraDx Platform, which is an integrated system comprised of a small, versatile Instrument, low-cost microfluidic Test Strips, and seamless, secure digital connectivity. The firm offers a menu of lab comparable tests on a single portable platform, with more than 30 assays on the market and in various stages of development, covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders. The company also supports laboratory testing in an accessible high-throughput format to leverage molecular laboratory operations. Its diagnostic testing solutions are being deployed globally by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools and others.
What is the stock price of LUMIRADX LTD today?
The current stock price of LMDX is 0.016 USD. The price decreased by -53.49% in the last trading session.
Does LUMIRADX LTD pay dividends?
LMDX does not pay a dividend.
What is the ChartMill rating of LUMIRADX LTD stock?
LMDX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists LMDX stock?
LMDX stock is listed on the Nasdaq exchange.
Is LUMIRADX LTD (LMDX) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LMDX.
What is the employee count for LMDX stock?
LUMIRADX LTD (LMDX) currently has 1210 employees.